Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Cuny

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Pituitary|October 20, 2014
Clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first-line therapy?Federico Gatto, Ludovica F Grasso, Elena Nazzari, et al.
Molecular and Cellular Endocrinology|February 22, 2012
Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretionThomas Cuny, Amira Mohamed, Thomas Graillon, et al.
European Journal of Endocrinology|October 31, 2022
Real-life clinical impact of a five-tiered classification of pituitary tumorsNicolas Sahakian, Romain Appay, Noémie Resseguier, et al.
Nature Reviews. Endocrinology|November 27, 2025
An update on hypophysitisLea Miquel, Benoit Testud, Frederique Albarel, et al.
European Journal of Endocrinology|July 5, 2020
Germinal defects of SDHx genes in patients with isolated pituitary adenomaGrégory Mougel, Arnaud Lagarde, Frédérique Albarel, et al.
World Journal of Surgery|June 28, 2022
Diagnostic Rechallenge with <sup>18</sup>F-FCH PET/CT Often Allows Minimally Invasive Parathyroidectomy While Maintaining Exceptional Cure RatesShani Goren, Nunzia Cinzia Paladino, Shachar Laks, et al.
European Journal of Endocrinology|November 10, 2025
Long-term tocilizumab therapy in patients with corticosteroid-resistant active moderate-to-severe thyroid eye diseaseFlorian Dalmas, Clémence Foing, Geneviève Darrason, et al.
Endocrine-Related Cancer|June 9, 2016
In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cellsThomas Cuny, Caroline Zeiller, Martin Bidlingmaier, et al.
Plos Neglected Tropical Diseases|July 12, 2019
The introduction of new hosts with human trade shapes the extant distribution of Toxoplasma gondii lineagesLokman Galal, Amedine Sarr, Thomas Cuny, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2026
3D volume growth rate may open new perspectives for the classification of aggressive pituitary adenomasThomas Graillon, Emeline Tabouret, Romain Appay, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Pituitary|October 20, 2014
Clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first-line therapy?Federico Gatto, Ludovica F Grasso, Elena Nazzari, et al.
Molecular and Cellular Endocrinology|February 22, 2012
Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretionThomas Cuny, Amira Mohamed, Thomas Graillon, et al.
European Journal of Endocrinology|October 31, 2022
Real-life clinical impact of a five-tiered classification of pituitary tumorsNicolas Sahakian, Romain Appay, Noémie Resseguier, et al.
Nature Reviews. Endocrinology|November 27, 2025
An update on hypophysitisLea Miquel, Benoit Testud, Frederique Albarel, et al.
European Journal of Endocrinology|July 5, 2020
Germinal defects of SDHx genes in patients with isolated pituitary adenomaGrégory Mougel, Arnaud Lagarde, Frédérique Albarel, et al.
World Journal of Surgery|June 28, 2022
Diagnostic Rechallenge with <sup>18</sup>F-FCH PET/CT Often Allows Minimally Invasive Parathyroidectomy While Maintaining Exceptional Cure RatesShani Goren, Nunzia Cinzia Paladino, Shachar Laks, et al.
European Journal of Endocrinology|November 10, 2025
Long-term tocilizumab therapy in patients with corticosteroid-resistant active moderate-to-severe thyroid eye diseaseFlorian Dalmas, Clémence Foing, Geneviève Darrason, et al.
Endocrine-Related Cancer|June 9, 2016
In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cellsThomas Cuny, Caroline Zeiller, Martin Bidlingmaier, et al.
Plos Neglected Tropical Diseases|July 12, 2019
The introduction of new hosts with human trade shapes the extant distribution of Toxoplasma gondii lineagesLokman Galal, Amedine Sarr, Thomas Cuny, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2026
3D volume growth rate may open new perspectives for the classification of aggressive pituitary adenomasThomas Graillon, Emeline Tabouret, Romain Appay, et al.
Pageof 9